Litigation Facts


Here are some of the litigation facts:
  • Joudry v. Janssen Pharmaceuticals et. al.: Rosalba Joudry, a resident of Ontario, filed the first INVOKANA lawsuit in Canada on September 10, 2015. The case formed the first part of a class action lawsuit seeking more than $1 billion for victims in that country. Ms. Joudry claims that she experienced kidney failure after taking the medication for 8 months. Janssen is charged with negligence in testing the drug and failing to provide a proper warning about complications.
  • Anzo v. Janssen Research & Development et al.: Jennifer Anzo filed the first INVOKANA lawsuit in the United States on October 26, 2015, in California. Court documents indicate that Anzo was hospitalized for ketoacidosis in October 2013 after taking the medication. She experienced several side effects including difficulty breathing, nausea, vomiting, abdominal pain, dehydration and low blood pressure. The case alleges that Janssen failed to warn physicians and patients adequately about the risks.
  • Counts v. Janssen Pharmaceuticals Inc. et al.: The first case against the maker of INVOKANA for kidney damage was filed in Illinois on October 28, 2015. Court papers note that Mr. Counts was prescribed the diabetes medicine in February of 2015 and suffered severe kidney damage. The lawsuit names the Japanese drug company Mitsubishi Tanabe Pharma Corp., which makes the drug, and Janssen Pharmaceuticals, which sells the medicine in North America.
  • Portnoff v. Janssen Pharmaceuticals Shortly after the FDA issued new safety alerts about INVOKANA causing ketoacidosis and urinary tract infections, Arthur Portnoff filed a lawsuit on December 10, 2015 in Pennsylvania. Court documents note that he started taking the drug in November 2014 and was diagnosed with ketoacidosis a few months later. The lawsuit claims that Janssen was aware of the elevated blood acid risks of INVOKANA but did not warn physicians or patients.
  • Collie v. Janssen Pharmaceuticals Inc., et al.: Luana Jean Collie filed an INVOKANA lawsuit in Alabama on December 15, 2015. Court papers indicate that she started taking the medicine in December 2014 and later developed diabetic ketoacidosis. The case claims that Janssen did not fulfill its obligation to consumers, misconstrued the drug's safety and hid the risks. She is seeking damages for past and future medical costs, pain and suffering as well as compensatory and punitive damages.


1 (855) 598-3998